Earlier this week, NHS England said that production problems at German company Heraeus Medical – which is the main supplier ...

The agreement gives MSD (known as Merck & Co in the US and Canada) access to the Mayo Clinic Platform architecture – which ...

The FDA plans to adopt a new policy that will do away with the default requirement to base regulatory filings for new medicines on two pivotal trials, according to Commissioner Marty Makary.

The three-year study – led by mental health data science company Akrivia Health in partnership with Cardiff University – will ...

Texas Attorney General Ken Paxton has filed a lawsuit against Sanofi, claiming the company bribed doctors to prescribe its medicines, in the state's latest broadside against pharma groups.

Daiichi Sankyo has named John Tsai as its new chief medical officer (CMO), replacing Ken Takeshita, who is stepping down after five years in the role on 1st April.

Managing bipolar I disorder (BD-I) is a long-term commitment, and factors such as symptoms and side effects influence ...

A complete response letter (CRL) was sent by the FDA for Disc's bitopertin for erythropoietic protoporphyria (EPP), which was ...

Storage specialist appoints new chief executive. Astoriom, a UK specialist in R&D sample storage, named Will Edwards as CEO.

Politico has said that O'Neill and HHS General Counsel Mike Stuart are leaving their current roles as part of a broader shake ...

Following his return from San Francisco and the JP Morgan Healthcare conference last month, editor-in-chief Jonah Comstock ...

Originally developed as a more-potent follow-up to Roche's long-established CD20-directed antibody Rituxan (rituximab) for ...